22892-95-1 Usage
Uses
Used in Organic Synthesis:
4-Chloro-3-chlorosulfonyl-5-nitrobenzoic acid is used as a key intermediate in the synthesis of various organic compounds. Its reactive groups facilitate multiple chemical reactions, making it a valuable component in the preparation of complex molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Chloro-3-chlorosulfonyl-5-nitrobenzoic acid is used as a building block for the development of new drugs. Its unique structure and reactivity allow for the creation of novel molecules with potential therapeutic applications.
Used in Chemical Research:
4-Chloro-3-chlorosulfonyl-5-nitrobenzoic acid is employed as a research tool in academic and industrial laboratories. Its reactivity and structural features make it an interesting subject for studying reaction mechanisms and exploring new synthetic pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 22892-95-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,8,9 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 22892-95:
(7*2)+(6*2)+(5*8)+(4*9)+(3*2)+(2*9)+(1*5)=131
131 % 10 = 1
So 22892-95-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H3Cl2NO6S/c8-6-4(10(13)14)1-3(7(11)12)2-5(6)17(9,15)16/h1-2H,(H,11,12)
22892-95-1Relevant academic research and scientific papers
AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
-
Paragraph 0890; 0893; 0894, (2015/07/22)
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
-
Paragraph 0889, (2015/09/22)
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
HEPATITIS B ANTIVIRAL AGENTS
-
Paragraph 0283; 0286; 0287, (2014/09/30)
Provided herein are compounds useful for the treatment of HBV infection in man.
3-Amino-5-sulfonylbenzoic acids
-
, (2008/06/13)
Aminobenzoic acids of the structure SPC1 Having saluretic and diuretic properties are described. These compounds are prepared by amidation of a 2-halo analog thereof or by alkylation of the free amino compound.
